Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases - PubMed (original) (raw)
Review
Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases
Silvia Fargion et al. Dig Liver Dis. 2011 Feb.
Abstract
Following the model of hereditary hemochromatosis, the possible role of iron overload as a cofactor for disease progression in acquired liver diseases has been investigated with controversial results. In recent years, progress has been made in understanding the regulation of iron metabolism, thereby allowing the evaluation of the mechanisms linking liver diseases to excessive iron accumulation. Indeed, deregulation of the transcription of hepcidin, emerging as the master regulator of systemic iron metabolism, has been implicated in the pathogenesis of hepatic iron overload in chronic liver diseases. Whatever the cause, hepatocellular iron deposition promotes liver fibrogenesis, while an emerging possible aggravating factor is represented by the strong link between iron stores and insulin resistance, a recently recognized risk factor for the progression of liver diseases. Overall, these pathogenic mechanisms, together with the known proliferative and mutagenic effect of excess iron, converge in determining an increased susceptibility to hepatocellular carcinoma. Finally, an association between serum ferritin levels and mortality in patients with end-stage liver disease has recently been reported. Prospective, randomized studies are required to evaluate whether iron depletion may reduce fibrosis progression, hepatocellular carcinoma development, and eventually mortality in patients with chronic liver diseases.
Copyright © 2010 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Similar articles
- [From iron accumulation to organ damage].
Zaccone V, Gasbarrini G. Zaccone V, et al. Minerva Med. 2012 Apr;103(2):123-40. Minerva Med. 2012. PMID: 22513517 Review. Italian. - Iron and the liver.
Corradini E, Ferrara F, Pietrangelo A. Corradini E, et al. Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:245-8. Pediatr Endocrinol Rev. 2004. PMID: 16462704 Review. - Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H, McFarlane I, Theurl I, Stadlmann S, Nemeth E, Oxley D, Ganz T, Halsall DJ, Cox TM, Vogel W. Zoller H, et al. Hepatology. 2005 Aug;42(2):466-72. doi: 10.1002/hep.20775. Hepatology. 2005. PMID: 15986403 - Diagnostic efficacy of tests for the detection of iron overload in chronic liver disease.
Valberg LS, Ghent CN, Lloyd DA, Frei JV, Chamberlain MJ. Valberg LS, et al. Can Med Assoc J. 1978 Aug 12;119(3):229-36. Can Med Assoc J. 1978. PMID: 679127 Free PMC article. - Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
McLaren GD, Muir WA, Kellermeyer RW. McLaren GD, et al. Crit Rev Clin Lab Sci. 1983;19(3):205-66. doi: 10.3109/10408368309165764. Crit Rev Clin Lab Sci. 1983. PMID: 6373141 Review.
Cited by
- Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver Disease.
Yu YC, Luu HN, Wang R, Thomas CE, Glynn NW, Youk AO, Behari J, Yuan JM. Yu YC, et al. Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):230-235. doi: 10.1158/1055-9965.EPI-21-0754. Epub 2021 Oct 14. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 34649958 Free PMC article. - Hepatic iron overload and hepatocellular carcinoma.
Kew MC. Kew MC. Liver Cancer. 2014 Mar;3(1):31-40. doi: 10.1159/000343856. Liver Cancer. 2014. PMID: 24804175 Free PMC article. Review. - STEAP4: its emerging role in metabolism and homeostasis of cellular iron and copper.
Scarl RT, Lawrence CM, Gordon HM, Nunemaker CS. Scarl RT, et al. J Endocrinol. 2017 Sep;234(3):R123-R134. doi: 10.1530/JOE-16-0594. Epub 2017 Jun 2. J Endocrinol. 2017. PMID: 28576871 Free PMC article. Review. - Elevated transferrin saturation in individuals with alcohol use disorder: Association with HFE polymorphism and alcohol withdrawal severity.
Kroll DS, McPherson KL, Manza P, Schwandt ML, Shen PH, Goldman D, Diazgranados N, Wang GJ, Wiers CE, Volkow ND. Kroll DS, et al. Addict Biol. 2022 Mar;27(2):e13144. doi: 10.1111/adb.13144. Addict Biol. 2022. PMID: 35229939 Free PMC article. - Body iron, serum ferritin, and nonalcoholic fatty liver disease.
Shim JJ. Shim JJ. Korean J Hepatol. 2012 Mar;18(1):105-7. doi: 10.3350/kjhep.2012.18.1.105. Epub 2012 Mar 22. Korean J Hepatol. 2012. PMID: 22511912 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical